Table 1 Cost variables used as input in the economic model.
From: Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation
Variable | Value | 95% uncertainty range | Reference | Comment |
|---|---|---|---|---|
Atosiban (Tractocile) 6.5 mg | 35.47€ | 31.93–39.02€ | Ferring, data on file | Costs of diagnostics, monitoring and infusion fluids considered equal for all treatments; drug wastage accounted for; 19% VAT applied. |
Atosiban (Tractocile) 37.5 mg | 115.29€ | 103.76–126.82€ | Ferring, data on file | Costs of diagnostics, monitoring and infusion fluids considered equal for all treatments; drug wastage accounted for; 19% VAT applied. |
Fenoterol (Partusisten) 0.5 mg | 3.75€ | 3.37–4.12€ | Rote Liste [14] | Costs of diagnostics, monitoring and infusion fluids considered equal for all treatments; drug wastage accounted for; 19% VAT applied. |
Preterm labour, one hosp. day | 321.90€ | Fixed value | G-DRG 2007/2008 [13] | G-DRG O64B |
Preterm labour, more than one hosp. day | 1,742.90€ | Fixed value | G-DRG 2007/2008 [13] | G-DRG O64A |
Chest pain | 1,175.50€ | Fixed value | G-DRG 2007/2008 [13] | G-DRG FZ4Z, min. 2 hosp. days were assumed for cases with chest pain. |
Dyspnoea | 2,470.80€ | Fixed value | G-DRG 2007/2008 [13] | G-DRG E64D, min 2 hosp. days were assumed for cases with dyspnoea. |